Search Login Register

Orofacial Granulomatosis Summary

Description: A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. There is no consensus on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.

Also Known As: Granulomatosis, Orofacial; Granulomatoses, Orofacial; Orofacial Granulomatoses

Networked: 48 relevant articles (3 outcomes, 1 trials/studies) for this Disease

Key Drugs and Agents for Orofacial Granulomatosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Triamcinolone (Aristocort) : 1 outcome in 4 results : FDA 27
  2. Benzoates (Benzoate) : 1 outcome in 3 results : IBA
  3. infliximab (Remicade) : 1 outcome in 2 results : FDA 2
  4. Food Additives (Food Additive) : 1 study in 1 result : IBA
  5. Thalidomide (Thalomid) : 3 results : FDA 2
  6. Triamcinolone Acetonide (Azmacort) : 2 results : FDA 135 Generic
  7. T-Cell Antigen Receptors (T-Cell Receptor) : 2 results : IBA
  8. Mercury : 2 results : IBA
  9. DNA (Deoxyribonucleic Acid) : 2 results : IBA
  10. Cosmetics : 2 results : IBA
Show All >>

Diseases Related to Orofacial Granulomatosis

  1. Contact Dermatitis (Eczema, Contact)
  2. Crohn Disease (Crohn's Disease)
  3. Hypersensitivity (Allergy)
  4. Allergic Contact Dermatitis
  5. Aphthous Stomatitis (Aphthous Ulcer)
Show All >>

Key Therapies for Orofacial Granulomatosis

Efficacy Chart >>
  1. Injections : 1 outcome in 3 results
  2. Oral Medicine : 5 results
  3. Nerve Block (Nerve Blocks) : 2 results
  4. Solid-State Lasers : 1 result
  5. Low-Level Laser Therapy (LLLT) : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.